Looking for information about AVILA THERAPEUTICS HEADQUARTERS? Follow the links below to find all the information you are interested in. Addresses, telephones, emails, working hours and other useful information.


Avila Therapeutics, Inc. - Relationship Science

    https://relationshipscience.com/organization/avila-therapeutics-inc-863162
    Jul 14, 2019 · Headquarters. 45 Wiggins Avenue,Bedford, MA 01730. Type of Company. Private. Employees (Worldwide) 11 - 50. Industries. Pharmaceuticals Hospitals & Patient Services Medical Support Services Biotechnology. Company Description. Avila Therapeutics, Inc. researches and develops covalent drugs. The company was founded in 2007 and is headquartered in ...

Avila Therapeutics - Crunchbase Company Profile & Funding

    https://www.crunchbase.com/organization/avila-therapeutics
    Avila Therapeutics designs and develops covalent drugs for viral infections, cancers, and autoimmune diseases. It offers AVL-181, a small molecule hepatitis C virus protease inhibitor. Avila Therapeutics has a strategic alliance with Sanofi-Aventis. The company was incorporated in 2006 and is based in Waltham, Massachusetts. As of March 7,Founded: 2006

Avila Therapeutics Headquarters - Quidditch

    https://www.quidditch.org.au/a-office/avila-therapeutics-headquarters.html
    Headquarters Regions Greater Boston Area, East Coast, New England; Founded Date 2006; Founders Juswinder Singh, Roy Lobb; Operating Status Active; Last Funding Type Venture - Series Unknown; Legal Name Avila Therapeutics, Inc. Company Type For Profit; Contact Email [email protected]; Phone Number 781-891-0086Founded: 2006

Avila Therapeutics - Atlas Venture

    https://atlasventure.com/company/avila-therapeutics
    Nov 12, 2014 · Avila Therapeutics. In January 2012 Celgene (NASDAQ: CELG) acquired Avila Therapeutics to pursue development of the company’s Btk inhibitor and covalent drug discovery platform. Headquarters. Bedford, MA. Pipeline. Phase 2 Btk program advancing at Celgene.Headquarters: Bedford, MA

Avila Therapeutics Inc. - Company Profile - BCIQ

    https://www.biocentury.com/companies/avila_therapeutics_inc
    International biotechnology industry analysis, data and networking focused on translation, research, development, regulation, commercialization, partnering and funding.

Avila Therapeutics Company Profile: Acquisition ...

    https://pitchbook.com/profiles/company/51400-99
    Avila Therapeutics General Information Description. Developer of covalent drugs for viral infections, cancers and autoimmune diseases. The company offers AVL-181, a small molecule hepatitis C virus protease inhibitor.

Avila Therapeutics - Index

    https://index.co/company/avilatherapeutics
    Avila Therapeutics Technology Biotechnology Health Care Medical Pharmaceuticals Avila Therapeutics is a biotechnology company focused on the development of covalent drugs to treat cancer and other autoimmune diseases. ... Headquarters Explore United States No recent coverage

Avilar Therapeutics Company Profile: Valuation & Investors ...

    https://pitchbook.com/profiles/company/458371-27
    Dec 17, 2020 · Deal Type Date Amount Raised to Date Post-Val Status Stage; 1. Seed Round: 17-Dec-2020: $20.3M: 000.00: 000.00: Completed: Stealth

In addition to information on AVILA THERAPEUTICS HEADQUARTERS, our site contains many other interesting information about corporate offices. We invite you to view the pages with related information.

Related Corporate Office Information: